iCAD, INC. (NASDAQ:ICAD)

CAPS Rating: 2 out of 5

The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.

Recs

1
Player Avatar FoolNMe2 (34.30) Submitted: 5/19/2011 6:11:54 PM : Outperform Start Price: $1.09 ICAD Score: +323.21

Cancer diagnostic tools assist with elimination of subjective radiologist evaluations by providing quantitative evaluations of radiographs. Joined with GE going into China. Added a breast diagnositic tool to next upgrade.

Member Avatar OklaBoston (68.67) Submitted: 8/20/2012 2:24:12 PM
Recs: 0

The CFO bought on the open market just last week, and another website that tracks option exercises as well as open market transactions says insider ownership has gone up the last 6 months.

I'd join you in giving this a green thumb if it weren't currently ineligible.

Featured Broker Partners


Advertisement